Antheia Rakes In $17 Million in New Funding
MENLO PARK — Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains, announced $17 million in new funding via a government project agreement through the Biopharmaceutical Manufacturing Preparedness Consortium ( …